CG Oncology officer plans $61.9K stock sale

CG Oncology, Inc. (CGON) received a notice under Rule 144 that officer Ambaw Bellete plans to sell 826 shares of common stock on September 11, 2026, following a stock option exercise for cash.

Rhea-AI Filing Summary

CG Oncology, Inc. (CGON) received a notice under Rule 144 that officer Ambaw Bellete plans to sell 826 shares of common stock on September 11, 2026, following a stock option exercise for cash. The shares are to be sold through Morgan Stanley Smith Barney LLC on Nasdaq, and the notice also lists Bellete’s prior common stock sales over the preceding three months.

Key Figures

Shares proposed for sale: 826 shares Aggregate value of proposed sale: $61,950.00 Largest single recent sale: 100,000 shares +3 more

6 metrics

Shares proposed for sale 826 shares Planned sale of CG Oncology, Inc. common stock on September 11, 2026

Aggregate value of proposed sale $61,950.00 Value associated with 826 CGON common shares in the planned Rule 144 sale

Largest single recent sale 100,000 shares Common stock sold on August 19, 2026 by Ambaw Bellete

Proceeds from August 19, 2026 sale $7,954,105.00 Aggregate sale price for 100,000 CGON shares on August 19, 2026

Shares sold August 31, 2026 50,000 shares Common stock sold by Ambaw Bellete on August 31, 2026

Proceeds from August 31, 2026 sale $3,775,250.00 Aggregate sale price for 50,000 CGON shares on August 31, 2026

Key Terms

Rule 144, Stock Option Exercise, Securities To Be Sold

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 09/11/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities To Be Sold financial

"144: Securities To Be Sold Common | 09/11/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for CGON?

It discloses that officer Ambaw Bellete intends to sell 826 shares of CG Oncology, Inc. common stock on September 11, 2026 under Rule 144, following a stock option exercise for cash, using Morgan Stanley Smith Barney LLC as the broker.

How many CGON shares are proposed to be sold in this Form 144?

The filing states that 826 shares of CG Oncology, Inc. common stock are proposed to be sold. These shares are tied to a stock option exercise dated September 11, 2026, with the sale to occur through a brokerage account on Nasdaq.

What is the reported value of the CGON shares to be sold?

The Form 144 lists an aggregate value of $61,950.00 for the 826 CGON common shares proposed for sale on September 11, 2026, as part of the planned transaction disclosed in the notice.

Which broker is handling the planned CGON share sale?

The planned sale of 826 CGON common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, as disclosed in the Form 144 filing.

What prior CGON stock sales by Ambaw Bellete are disclosed?

The filing lists multiple prior CGON sales in the past three months, including 100,000 shares on August 19, 2026 for $7,954,105.00 and 50,000 shares on August 31, 2026 for $3,775,250.00, along with several additional transactions of varying sizes.

What is Rule 144 in relation to CGON’s Form 144 filing?

Rule 144 provides a safe harbor for the resale of restricted or control securities. The CGON filing is a notice that officer Ambaw Bellete intends to sell 826 common shares under this rule and includes information on recent sales that must be aggregated under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 05:11 PM Accepted by SEC EDGAR 09/11/2026 - 05:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007090
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CG ONCOLOGY, INC.
SEC File Number	001-41925
Address of Issuer	3000 Pegasus Park Drive SUITE 1640 Dallas TEXAS 75247
Phone	(949) 409-3700
Name of Person for Whose Account the Securities are To Be Sold	AMBAW BELLETE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	826	61950.00	88640375	09/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2026	Stock Option Exercise	Issuer			826	09/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	09/02/2026	29630	2299448.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/31/2026	50000	3775250.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/27/2026	5789	459560.92
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/25/2026	10551	839338.38
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/24/2026	5762	458185.02
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/19/2026	100000	7954105.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/17/2026	52438	4034894.35
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/14/2026	19364	1452635.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/13/2026	25989	1973970.86
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/12/2026	32137	2526514.53
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/11/2026	50000	3810255.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/10/2026	50000	3770580.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/07/2026	9250	696062.50
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/06/2026	75000	5672212.50
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	08/05/2026	25000	1837500.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/29/2026	4303	316270.50
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/28/2026	50000	3625195.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/27/2026	50000	3627995.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/23/2026	50000	3588620.00
AMBAW BELLETE 3000 Pegasus Park Drive SUITE 1640 Dallas TX 75247	Common	07/15/2026	52438	3816007.65

144: Remarks and Signature

Remarks
Date of Notice	09/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ambaw Bellete
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)